SABS: SAB Biotherapeutics, Inc. Stock

by  •  • Comments Off on SABS: SAB Biotherapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 35.70
Enterprise Value ($M) -19.81
Book Value ($M) 57.30
Book Value / Share 6.21
Price / Book 0.62
NCAV ($M) 32.27
NCAV / Share 3.50
Price / NCAV 1.11

Profitability (mra)
Return on Invested Capital (ROIC) -0.67
Return on Assets (ROA) -0.99
Return on Equity (ROE) -1.73

Liquidity (mrq)
Quick Ratio 5.45
Current Ratio 5.45

Balance Sheet (mrq) ($M)
Current Assets 58.91
Assets 83.94
Liabilities 26.64
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2.24
Operating Income -38.08
Net Income -42.19
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -25.12
Cash from Investing -0.15
Cash from Financing 66.77

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Radcliffe Capital Management, L.P. 0.00 -100.00
02-14 13G/A Commodore Capital Lp 3.50 -73.58
02-14 13G Rtw Investments, Lp 9.99
12-04 13G Biotechnology Value Fund L P 9.99

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-16 1,510 15,890 9.50
2024-05-15 303 1,794 16.89
2024-05-14 3,159 4,271 73.96
2024-05-13 2,138 12,185 17.55

(click for more detail)

Similar Companies
RNXT – RenovoRx, Inc. RVPH – Reviva Pharmaceuticals Holdings, Inc.
RZLT – Rezolute, Inc. SAVA – Cassava Sciences, Inc.
SBFM – Sunshine Biopharma, Inc.


Financial data and stock pages provided by
Fintel.io